Νέα Ζηλανδία - Αγγλικά - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - rabies vaccine, wistar pm/wi 38-1503-3m 2.5 [iu] - suspension for injection - 2.5 iu - active: rabies vaccine, wistar pm/wi 38-1503-3m 2.5 [iu] excipient: albumin neomycin sulfate water for injection - post exposure immunisation against rabies. pre-exposure immunisation in persons at special risk of contracting rabies.

Ιρλανδία - Αγγλικά - HPRA (Health Products Regulatory Authority)

gsk vaccines gmbh - inactivated rabies virus - powder and solvent for solution for injection - 2.5 international unit(s)/millilitre - rabies vaccines; rabies, inactivated, whole virus

Αυστραλία - Αγγλικά - Department of Health (Therapeutic Goods Administration)

sanofi-aventis australia pty ltd - rabies virus, quantity: 2.5 iu - injection, powder for - excipient ingredients: albumin; neomycin - idications as at 12 july 2004: post exposure immunisation against rabies. pre-exposure immunisation in persons at special risk of contracting rabies.

Κένυα - Αγγλικά - Pharmacy and Poisons Board

inactivated rabies vaccine - injection - inactivated rabies vaccine - antibacterials for systemic use

Ιρλανδία - Αγγλικά - HPRA (Health Products Regulatory Authority)

sanofi pasteur - inactivated rabies virus strain pm/wi 38 1503 3m - powder and solvent for suspension for injection - 2.5 international unit(s)/millilitre - rabies vaccines; rabies, inactivated, whole virus

Ιρλανδία - Αγγλικά - HPRA (Health Products Regulatory Authority)

sanofi pasteur msd ltd - rabies vaccine - suspension for injection - 2.5 iu/ml - rabies vaccines

Ιρλανδία - Αγγλικά - HPRA (Health Products Regulatory Authority)

gsk vaccines gmbh - rabies virus (flury lep) inactivated - infus/pdr/oral soln - >= 2.5 international unit(s)/millilitre - rabies vaccines; rabies, inactivated, whole virus

Νέα Ζηλανδία - Αγγλικά - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - rabies vaccine, wistar pm/wi 38-1503-3m 3.25 [iu] (target quantity per dose) - powder for injection with diluent - 3.25 iu - active: rabies vaccine, wistar pm/wi 38-1503-3m 3.25 [iu] (target quantity per dose) excipient: albumin hydrochloric acid bme medium - mineral salts, vitamins, amino acids including l-phenylalanine maltose sodium hydroxide sodium chloride water for injection - verorab is indicated for pre-exposure prophylaxis against rabies. verorab is indicated for post-exposure prophylaxis against rabies. verorab should be used in accordance with official local recommendations.

Αυστραλία - Αγγλικά - Department of Health (Therapeutic Goods Administration)

sanofi-aventis australia pty ltd - rabies virus -

Καναδάς - Αγγλικά - Health Canada

aventis pasteur limited - rabies vaccine inactivated (human diploid-cell culture) - powder for solution - 2.5unit - rabies vaccine inactivated (human diploid-cell culture) 2.5unit - vaccines